U.S. Announces Second Texas Screwworm Outbreak, Raising Alerts for Ranchers
AstraZeneca’s CEO Says AI Is Redefining How New Medicines Are Built
PacificSource cuts 97 Oregon jobs as it steps back from state health‑insurance market
Rural Health Care Infrastructure: Emerging Trends and Key Considerations
The Dual Scourge: Confronting Ebola and the Assault on Healthcare Heroes
The Affordable Care Act’s Enrollment Crunch: What’s Happening Now
Pope Francis Sounds Alarm: The Ethical Imperative for AI in Warfare
The Supreme Court, Danco, and the Shifting Tides of Abortion Access: A Battle Over Mail-Order Medication
Dr. Oz Calls for Sweeping 50-State Audit of Medicaid Program
Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance
Hollywood Writers Strike: Tentative Deal Reached, Relief on the Horizon
Aerospace & Healthcare Soar: A Late March Filing Frenzy Reveals Market Hotspots
Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape
Navigating Turbulent Waters: Jim Cramer's Playbook for Market Jitters Amidst Geopolitical Tensions
The Shifting Sands of US Drug Pricing: Why Big Pharma Investors are on Edge
A Double Whammy: Why Healthcare Giants Like UnitedHealth, CVS, and Humana Are Bracing for a Storm
A Human Perspective on Abbott Labs: When the Market Stumbles, Long-Term Value Emerges
Jim Cramer's Enthusiastic Endorsement: Medline Deemed "Unbelievable" and a Strong "Buy"
The J.P. Morgan Healthcare Conference 2026: Day 2 Unpacked
A Holiday Season Surge: Medline's Big Debut Captivates the IPO Market Just Before Christmas
A Shifting Landscape: Trump, Cannabis, and the Power of the Purse
The Reckoning Arrives: UnitedHealth Receives Crucial External Review Results Post-Cyberattack
Beyond Sleep: Eight Sleep's Grand Vision to Turn Smart Beds into Certified Medical Devices
A Looming Healthcare Showdown: Republicans Propose New Paths as Obamacare Subsidies Face Expiration
Reimagining Healthcare: Shifting Power Back to Patients
The Governor's Third Act: Ned Lamont Steps Back into the Fray, Eyes Another Term
The Quiet Ascent: Chris Powell's Journey to Lead Freeman's Operations
The Eleventh-Hour Hustle: Whispers of a Deal to Dodge D.C.'s Shutdown Bullet
The Weekend Slow Dance: When Capitol Hill Seeks Answers, Slowly
The Eleventh-Hour Hustle: Washington's Slow Crawl to the Brink
Standoff at the Border: Trump Digs In as Shutdown Looms
The Medicare Part B Late Enrollment Penalty: A Lifelong Burden Many Never See Coming
The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp
The Unseen Momentum: Aadi Bioscience's Remarkable Ascent and the Hope it Carries
Cigna's Unsettling Paradox: Stellar Earnings, Yet the Market Balked
Baxter's Unsettling Quarter: A Deep Dive into Disappointment and a Dimmed Horizon
The Unstoppable Pulse: HCA Healthcare's Surprising Triumph
Turbulence in Healthcare: State's Second-Largest Insurer Sheds 250 Jobs
Virtua Health System Announces Major Workforce Reduction Amidst Financial Headwinds
Healthcare Giant Tower Health Announces Over 500 Layoffs Across New Jersey and Pennsylvania
Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!
Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled
Johnson & Johnson Soars Past Expectations with Stellar Q3 Earnings, Driven by Pharmaceutical and MedTech Growth